Venture Capital

On Biotech Hangout this week, hosts Daphne Zohar, Tim Opler, Chris Garabedian, Bruce Booth and Michal Preminger are joined by Andy Plump, President, Research & Development at Takeda, and Jay Bradner, Physician-Scientist and former President of the Novartis Institutes for BioMedical Research. They talk pharma productivity and its impact on M&A, new models for advancing and funding medicine and why we need them and what a pharmaceutical R&D head actually does. Andy and Jay discuss conflicts between research and commercial departments, share their experiences, insights and strategies learned from their careers in R&D executive roles and describe the elements needed for a biotech company to be successful long-term. The hosts end with a lively discussion of business models in the industry from venture creation to listed “truffle hunters” to pharma efforts at being more entrepreneurial.